AndyForce Obtains Export Approval for Influenza Rapid Diagnostic Kit..."Secures Simultaneous Diagnosis Portfolio"

[Asia Economy Reporter Hyunseok Yoo] AndyForce announced on the 22nd that it has obtained export approval from the Ministry of Food and Drug Safety (MFDS) for the rapid diagnostic kit for influenza virus, ‘ND Influenza A&B Ag Test’.

With this approval, AndyForce is expected to soon launch a rapid diagnostic kit for simultaneous diagnosis, following its molecular diagnostic-based COVID-19-influenza simultaneous diagnostic kit.

AndyForce’s rapid diagnostic kit for influenza virus can determine the presence of influenza virus types A and B within 15 minutes. Separately from this approval, AndyForce is also in the process of obtaining export approval for the ‘COVID-19-Influenza Antigen Rapid Diagnostic Kit,’ aiming to secure the entire portfolio of simultaneous diagnostic products soon.

An AndyForce official stated, “With the export approval of the influenza rapid diagnostic kit followed by the COVID-19-influenza antigen rapid diagnostic kit, AndyForce will secure all product lines for simultaneous diagnosis of COVID-19 and influenza. As the season for seasonal flu approaches, the demand for simultaneous diagnostic kits capable of testing both COVID-19 and influenza is expected to increase significantly.”